NCM·Healthcare·$443M·#208 / 520 in Healthcare
IPSC Century Therapeutics, Inc.
52SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY40
STABILITY36
VALUATION50
GOVERNANCE37
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+1556.8%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
7 months
16
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
27.4%
78
< 25% strong
Price / Sales
Market cap relative to trailing revenue
N/A
50
< 3x strong
Rule of 40
Growth rate plus operating margin
1547
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
8.2%
56
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+108.9%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE IPSC WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when IPSC's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.